SCNI
$0.72+0.02 (+2.86%)
Market OpenAs of Mar 17, 5:46 PM UTC
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$0.72
Potential Upside
209009.5%
Whystock Fair Value$1505.59
Price
UndervaluedFair ValueOvervalued
Fundamentals
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nano...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.30M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
0.18
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.90
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
1791.99%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.53
Recent News
No recent news found.